Fulcrum Asset Management LLP bought a new stake in Revvity Inc. (NYSE:RVTY – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,366 shares of the company’s stock, valued at approximately $514,000.
A number of other institutional investors also recently modified their holdings of RVTY. Allspring Global Investments Holdings LLC boosted its holdings in Revvity by 0.9% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,248,998 shares of the company’s stock valued at $335,236,000 after purchasing an additional 21,124 shares during the period. Heritage Family Offices LLP acquired a new position in shares of Revvity during the 3rd quarter worth approximately $37,000. Westside Investment Management Inc. bought a new position in shares of Revvity during the third quarter worth approximately $2,359,000. Kestra Advisory Services LLC increased its holdings in shares of Revvity by 3.4% during the third quarter. Kestra Advisory Services LLC now owns 10,602 shares of the company’s stock worth $1,621,000 after purchasing an additional 352 shares during the period. Finally, Commonwealth Equity Services LLC increased its holdings in shares of Revvity by 3.3% during the third quarter. Commonwealth Equity Services LLC now owns 11,491 shares of the company’s stock worth $1,757,000 after purchasing an additional 365 shares during the period. Institutional investors own 86.65% of the company’s stock.
Revvity Price Performance
RVTY stock opened at $154.60 on Monday. The company has a quick ratio of 2.10, a current ratio of 2.65 and a debt-to-equity ratio of 0.36. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $171.74. The firm has a market cap of $17.26 billion, a P/E ratio of 68.41, a P/E/G ratio of 2.70 and a beta of 1.08. The company’s 50-day moving average price is $150.48 and its two-hundred day moving average price is $114.30.
Revvity (NYSE:RVTY – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $1.38 EPS for the quarter, beating the consensus estimate of $1.30 by $0.08. Revvity had a net margin of 8.61% and a return on equity of 8.64%. The company had revenue of $728.90 million during the quarter, compared to analysts’ expectations of $694.73 million. During the same period in the previous year, the company earned $1.18 EPS. The business’s revenue for the quarter was up 4.3% compared to the same quarter last year. On average, analysts anticipate that Revvity Inc. will post 5.42 earnings per share for the current fiscal year.
Revvity Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 12th. Investors of record on Friday, January 22nd will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 22nd. Revvity’s dividend payout ratio (DPR) is 12.39%.
Insider Buying and Selling
In other Revvity news, insider Tajinder S. Vohra sold 7,330 shares of the firm’s stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $140.88, for a total value of $1,032,650.40. Following the sale, the insider owned 6,635 shares of the company’s stock, valued at approximately $934,738.80. This trade represents a 52.49% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Maxwell Krakowiak sold 1,631 shares of the firm’s stock in a transaction on Monday, September 21st. The shares were sold at an average price of $144.53, for a total value of $235,728.43. Following the completion of the sale, the insider directly owned 14,781 shares in the company, valued at approximately $2,136,297.93. This represents a 9.94% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 9,045 shares of company stock worth $1,281,439 over the last three months. 0.85% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
RVTY has been the subject of a number of analyst reports. Barclays lifted their price target on shares of Revvity from $160.00 to $175.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 4th. Wall Street Zen raised Revvity from a “hold” rating to a “buy” rating in a research report on Saturday. UBS Group started coverage on Revvity in a research note on Wednesday, September 9th. They set a “neutral” rating and a $140.00 price objective on the stock. Royal Bank Of Canada lifted their price objective on Revvity from $135.00 to $172.00 and gave the company a “sector perform” rating in a report on Wednesday, November 4th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Revvity in a report on Thursday. Six analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. Based on data from MarketBeat, Revvity presently has a consensus rating of “Hold” and an average target price of $133.86.
Check Out Our Latest Stock Analysis on Revvity
Revvity Profile
Revvity, Inc. develops and supplies products and services for life sciences research and clinical diagnostics. Its offerings include instruments, reagents, software and related services used by pharmaceutical and biotechnology companies, academic and government research institutions, hospitals and clinical laboratories. The company’s work spans areas such as drug discovery and development, genetic testing, newborn screening and other diagnostic applications. Its technologies help researchers and healthcare providers analyze biological samples and generate information used in research and patient care.
See Also
- Five stocks we like better than Revvity
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY – Free Report).
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
